{"paperId": "44795e46d8c56f279619b34ecf78989937c8fc0a", "publicationVenue": {"id": "ba627f0e-abf9-4f01-8146-73118f4ebaf9", "name": "The Lancet", "type": "journal", "alternate_names": ["Lancet"], "issn": "0923-7577", "alternate_issns": ["0140-6736"], "url": "http://www.elsevier.com/wps/find/journaldescription.cws_home/31066/description#description", "alternate_urls": ["http://www.thelancet.com/", "https://www.thelancet.com/"]}, "title": "Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial", "abstract": null, "venue": "The Lancet", "year": 2022, "fieldsOfStudy": ["Medicine"], "publicationTypes": ["JournalArticle"], "publicationDate": "2022-06-01", "journal": {"name": "The Lancet", "pages": "2200-2211", "volume": "399"}, "authors": [{"authorId": "2517321", "name": "B. Sands"}, {"authorId": "144324915", "name": "P. Irving"}, {"authorId": "2281389796", "name": "T. Hoops"}, {"authorId": "82552613", "name": "J. Izanec"}, {"authorId": "66187691", "name": "Long-Long Gao"}, {"authorId": "47402954", "name": "C. Gasink"}, {"authorId": "46748933", "name": "A. Greenspan"}, {"authorId": "3648080", "name": "M. Allez"}, {"authorId": "2379943", "name": "S. Danese"}, {"authorId": "2096667566", "name": "S. Hanauer"}, {"authorId": "145600793", "name": "V. Jairath"}, {"authorId": "2097657170", "name": "T. Kuehbacher"}, {"authorId": "2109240361", "name": "J. Lewis"}, {"authorId": "6111904", "name": "E. Loftus"}, {"authorId": "39060559", "name": "E. Mih\u00e1ly"}, {"authorId": "6591814", "name": "R. Panaccione"}, {"authorId": "5317126", "name": "E. Scherl"}, {"authorId": "14472678", "name": "O. Shchukina"}, {"authorId": "4349130", "name": "W. Sandborn"}, {"authorId": "37274727", "name": "A. Afzali"}, {"authorId": "152188950", "name": "L. Aitova"}, {"authorId": "80534724", "name": "X. A. Mant\u00e9"}, {"authorId": "48209280", "name": "I. Altorjay"}, {"authorId": "2064401101", "name": "F. A. Arias"}, {"authorId": "6852018", "name": "A. Armuzzi"}, {"authorId": "2169464068", "name": "Monika Augustyn"}, {"authorId": "8123659", "name": "M. Bafutto"}, {"authorId": "39967057", "name": "J. Barrio"}, {"authorId": "144826505", "name": "J. Begun"}, {"authorId": "2169437225", "name": "Clint E Behrend"}, {"authorId": "7470013", "name": "G. Bezemer"}, {"authorId": "46888155", "name": "G. Bonnaud"}, {"authorId": "1490918970", "name": "M. Brankovi\u0107"}, {"authorId": "82002822", "name": "Ik Jang Byung"}, {"authorId": "2097055831", "name": "X. C. Calvo"}, {"authorId": "3805818", "name": "Karen A. Chachu"}, {"authorId": "4238567", "name": "J. Chebli"}, {"authorId": "1957387", "name": "J. Cheon"}, {"authorId": "1398440846", "name": "H. Cicho\u017c-Lach"}, {"authorId": "2070152690", "name": "L. Clark"}, {"authorId": "120230754", "name": "Fraser Cummings"}, {"authorId": "123164071", "name": "Kunali Dalal"}, {"authorId": "2068591565", "name": "N. D. Boer"}, {"authorId": "113445481", "name": "M. L. A. Ferrari"}, {"authorId": "49209444", "name": "\u00c9. D\u00e9silets"}, {"authorId": "9767151", "name": "P. Dugalic"}, {"authorId": "123866406", "name": "G. Duvall"}, {"authorId": "15934150", "name": "O. Fedorishina"}, {"authorId": "40406957", "name": "R. Filip"}, {"authorId": "31906969", "name": "C. Flores"}, {"authorId": "34244681", "name": "R. Fogel"}, {"authorId": "31651990", "name": "James Fon"}, {"authorId": "104501794", "name": "Micah Frankel"}, {"authorId": "13710081", "name": "K. Friedenberg"}, {"authorId": "145750630", "name": "W. Fries"}, {"authorId": "95478585", "name": "V. Galina"}, {"authorId": "6291383", "name": "P. Gietka"}, {"authorId": "4609018", "name": "R. Goel"}, {"authorId": "4789561", "name": "P. Hasselblatt"}, {"authorId": "5487355", "name": "H. Herfarth"}, {"authorId": "4768103", "name": "L. Hersz\u00e9nyi"}, {"authorId": "4633923", "name": "P. Hindryckx"}, {"authorId": "152541638", "name": "F. Hoentjen"}, {"authorId": "2263160054", "name": "C. H. T. Horje"}, {"authorId": "15182889", "name": "Satish Iduru"}, {"authorId": "144324915", "name": "P. Irving"}, {"authorId": "2405228", "name": "R. Isfort"}, {"authorId": "2111329266", "name": "Michael Jones"}, {"authorId": "83410772", "name": "D. Kalimullina"}, {"authorId": "2067681972", "name": "Jeff B. Katz"}, {"authorId": "4076697", "name": "Manreet Kaur"}, {"authorId": "47970577", "name": "S. Khurana"}, {"authorId": "2145430833", "name": "Joo Sung Kim"}, {"authorId": "2118636403", "name": "Youngho Kim"}, {"authorId": "11277006", "name": "D. Kleczkowski"}, {"authorId": "40595456", "name": "Slavko Knezevi\u0107"}, {"authorId": "2088857253", "name": "A. Knoll"}, {"authorId": "3210233", "name": "L. Korman"}, {"authorId": "7548484", "name": "I. Kotzev"}, {"authorId": "52005192", "name": "A. Kulyapin"}, {"authorId": "2145140445", "name": "Kang Moon Lee"}, {"authorId": "1413643121", "name": "D. Leemreis"}, {"authorId": "5591292", "name": "J. Leszczyszyn"}, {"authorId": "8144078", "name": "J. Limdi"}, {"authorId": "1419856441", "name": "J. Lissauer"}, {"authorId": "6111904", "name": "E. Loftus"}, {"authorId": "1390160687", "name": "E. Ma\u0142ecka-Panas"}, {"authorId": "122045238", "name": "J. Marshall"}, {"authorId": "39060559", "name": "E. Mih\u00e1ly"}, {"authorId": "2169465069", "name": "Lukas Milan"}, {"authorId": "143837376", "name": "G. Monteleone"}, {"authorId": "48810335", "name": "A. Nagorni"}, {"authorId": "3536922", "name": "D. Owczarek"}, {"authorId": "2169440719", "name": "Nichole Palekar"}, {"authorId": "1856942", "name": "Y. Park"}, {"authorId": "4981588", "name": "S. Park"}, {"authorId": "144378875", "name": "R. Parra"}, {"authorId": "6488580", "name": "\u00c1. Patai"}, {"authorId": "2083782", "name": "K. Patel"}, {"authorId": "2011887447", "name": "Bhaktasharan Patel"}, {"authorId": "91628533", "name": "A. Pershko"}, {"authorId": "49108854", "name": "E. Petrova"}, {"authorId": "4079526", "name": "G. P. Chambrun"}, {"authorId": "145438529", "name": "C. Randall"}, {"authorId": "2069231521", "name": "S. R. Men\u00e9ndez"}, {"authorId": "94527929", "name": "T. Ritter"}, {"authorId": "50270793", "name": "M. Rivero"}, {"authorId": "3962674", "name": "X. Roblin"}, {"authorId": "50758776", "name": "R. Rocca"}, {"authorId": "39840159", "name": "J. Romatowski"}, {"authorId": "6012226", "name": "G. Rydzewska"}, {"authorId": "5281849", "name": "S. Saibeni"}, {"authorId": "5068197", "name": "B. Salzberg"}, {"authorId": "2053962380", "name": "H. Sarles"}, {"authorId": "2059100861", "name": "John Saunders"}, {"authorId": "51933126", "name": "E. Savarino"}, {"authorId": "15780108", "name": "Z. \u0160erclov\u00e1"}, {"authorId": "14472678", "name": "O. Shchukina"}, {"authorId": "144413800", "name": "J. Siegel"}, {"authorId": "90087262", "name": "Najm Soofi"}, {"authorId": "144356071", "name": "M. Sparrow"}, {"authorId": "81043346", "name": "D. Stokesberry"}, {"authorId": "3636596", "name": "D. Suiter"}, {"authorId": "5316144", "name": "P. Svorcan"}, {"authorId": "32118395", "name": "A. Tkachev"}, {"authorId": "108706734", "name": "N. Tsonev"}, {"authorId": "2169437243", "name": "Krist\u00f3f T\u00fcnde"}, {"authorId": "17107420", "name": "J. Ulbrych"}, {"authorId": "40594618", "name": "T. Van\u0306\u00e1sek"}, {"authorId": "49363355", "name": "M. Varga"}, {"authorId": "3615640", "name": "S. Vermeire"}, {"authorId": "5485923", "name": "R. V. Lid\u00f3n"}, {"authorId": "2112681323", "name": "Michael L. Weiss"}, {"authorId": "40134960", "name": "E. Wesley"}, {"authorId": "2146501", "name": "N. Winstead"}, {"authorId": "2066497062", "name": "K. W\u00f3jcik"}, {"authorId": "47662747", "name": "J. Wypych"}, {"authorId": "10369743", "name": "C. Zaltman"}, {"authorId": "2169471979", "name": "Zadorova Zdena"}], "citations": [{"paperId": "a2bd95a3ce2a38652440e943d365dfe1b58bc1e8", "title": "The association of three vaccination doses with reduced gastrointestinal symptoms after severe acute respiratory syndrome coronavirus 2 infections in patients with inflammatory bowel disease"}, {"paperId": "0ae96006a7a57317cd476a260f6bc2f410526bcf", "title": "Optimal Management of Refractory Crohn\u2019s Disease: Current Landscape and Future Direction"}, {"paperId": "e594ad6a48286d56f15ff6317ce20828cd3f051e", "title": "Ustekinumab in the Treatment of Inflammatory Bowel Diseases: Evolving Paradigms"}, {"paperId": "2e21ae468a15db835d36bfc94c3a57290374eef9", "title": "Research progress of Ustekinumab in the treatment of inflammatory bowel disease"}, {"paperId": "383a465a5bb774cbaa493452819167b8ce9a89e8", "title": "Predictive, preventive and personalised approach as a conceptual and technological innovation in primary and secondary care of inflammatory bowel disease benefiting affected individuals and populations"}, {"paperId": "1dfd0058c8df1524c2516a5800fbead83e1c6154", "title": "A bibliometric and visual analysis of the use of ustekinumab in Crohn\u2019s disease using CiteSpace"}, {"paperId": "297ff526d968e2ee0d205ce8d34d5214a258e8b0", "title": "Controversies in the management of anti-TNF therapy in patients with Crohn\u2019s disease: a Delphi consensus"}, {"paperId": "4941c2ce8f65464c7430656ee100d2d304e956d7", "title": "The Role of IL-23 Inhibitors in Crohn\u2019s Disease"}, {"paperId": "38341f7be4873d76d67102f033b2f1d12d46541b", "title": "Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds?"}, {"paperId": "d90fafc78ac0f843cf038393599f17d8d1aa1d81", "title": "Personalized Treatment for Crohn\u2019s Disease: Current Approaches and Future Directions"}, {"paperId": "b1f36c4566b796ff425b44472b1fd7a9d3947f7d", "title": "Use of real-world data to assess the effectiveness of ustekinumab in treating IBD patients: a retrospective linked database study in northwest London"}, {"paperId": "67c53a262cf8afbfb40761103f191a2a1cc86b3d", "title": "Personalizing treatment selection in Crohn\u2019s disease: a meta-analysis of individual participant data from fifteen randomized controlled trials"}, {"paperId": "872313e1513cc0335063b1a723defa110dfbf06b", "title": "Sequential regression and simulation: a method for estimating causal effects from heterogeneous clinical trials without a common control group"}, {"paperId": "5900428730eb75682029d7cded408eed876569fd", "title": "A Real-World Prospective Cohort Study of Patients With Newly Diagnosed Crohn\u2019s Disease Treated by a Multidisciplinary Team: 1-Year Outcomes"}, {"paperId": "11432c5ed076b43f18717dd77f689382c830035b", "title": "Choosing Therapy for Moderate to Severe Crohn\u2019s Disease"}, {"paperId": "bccd20e18c8e9287e1235c4c21ac473d23425942", "title": "Choosing the Right Therapy at the Right Time for Pediatric Inflammatory Bowel Disease: Does Sequence Matter."}, {"paperId": "7f7be3d8cb5a4326640a9085fcd8f7db45ee8ef3", "title": "Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing"}, {"paperId": "c9d744e361ab5c1ae2bdf19b5a1e2074613abbf2", "title": "The Future of Advanced Therapies for Pediatric Crohn\u2019s Disease"}, {"paperId": "01617b567802e68242fd75c22626b99034922237", "title": "Long-term persistence and other treatment patterns among bio-na\u00efve patients with Crohn\u2019s disease treated with ustekinumab or adalimumab"}, {"paperId": "6de66ce54fc887a980c97c36093a47ef80fa3b27", "title": "Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-na\u00efve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study."}, {"paperId": "3df3db5876c3efbc850557d00ad92dccac336d78", "title": "Prioritization in inflammatory bowel disease therapy"}, {"paperId": "6c4f6bbdda638ee55025bdb3442d93f83d2d7b4a", "title": "Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies."}, {"paperId": "68079c97c5255b1bed5e4a5bab26634a7207a3fd", "title": "Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn\u2019s Disease: Systematic Review and Meta-Analysis"}, {"paperId": "20ac371b4176eabdd9ea5c531098da966047a364", "title": "Targeting IL-23 for IBD: Rationale and Progress to Date"}, {"paperId": "29c2a5b86cb579cdefe981ad14d85e780c682456", "title": "Combination non tumour necrosis factor biologic and small\u2010molecule therapy in a patient with ankylosing spondylitis and Crohn disease"}, {"paperId": "5f2f667d5c2f2096118e2c72234e25c0c940392a", "title": "Negative regulatory NLRs mitigate inflammation via NF-\u03baB pathway signaling in inflammatory bowel disease"}, {"paperId": "a5e8977dfb387ba6c2b3517b7f5ac8a1307ac266", "title": "Targeting IL23p19 using risankizumab for the management of moderate-to-severely active Crohn's disease"}, {"paperId": "3483a60b94a59971305d7d296c348a561d0313fe", "title": "Use of biologics for the management of Crohn's disease."}, {"paperId": "96405085b079fc4f738e63e73fef8d21af44f6e4", "title": "IL-12 and IL-23 pathway inhibition in inflammatory bowel disease"}, {"paperId": "7ebb2dd50b177c3151ce8aeabba428455c577d95", "title": "Biologics Imperative: Drug Positioning After First-Line Treatment with Anti-TNFs"}, {"paperId": "b7f412bee0c3deead40bd1e5b1236639ca8708de", "title": "Personalizing therapy selection in inflammatory bowel disease"}, {"paperId": "543b9324b2edc273109194b2b6160d7e8c727b7e", "title": "Comparison of Effectiveness and Safety of Ustekinumab and Adalimumab As Induction or Maintenance Therapy in Patients With Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis"}, {"paperId": "61905d41b0de5304fe8f226a8225adeccbec6645", "title": "Oxidative Stress, Inflammation, Gut Dysbiosis: What Can Polyphenols Do in Inflammatory Bowel Disease?"}, {"paperId": "8a519af2e12791e259acb6d73dbfdfac5b04ed3b", "title": "Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease"}, {"paperId": "d68a93fc2ae74a53392b58a29c3c5668a67415a3", "title": "Precision medicine in inflammatory bowel disease: Individualizing the use of biologics and small molecule therapies"}, {"paperId": "9c4d7795a941e0961579e9cef96fba6c85349acf", "title": "Predictive factors of the clinical efficacy of ustekinumab in patients with refractory Crohn\u2019s disease: tertiary centers experience in Japan"}, {"paperId": "822e2b453d63094da709e5bcfe55bbb795959608", "title": "Systematic Review and Meta-Analysis of Observational Studies on the Effectiveness and Safety of Ustekinumab among Patients with Inflammatory Bowel Disease in Eastern and Western Countries"}, {"paperId": "9163ff65a009895b08959db341721f2235c64ddd", "title": "The Winning Line Up: Positioning Advanced Therapies for Ulcerative Colitis"}, {"paperId": "2daa8858cea8a52af775975d665209d8b3bbe8b3", "title": "Incorporation of Plant-Based Diet Surpasses Current Standards in Therapeutic Outcomes in Inflammatory Bowel Disease"}, {"paperId": "8651a459c39e1df379e806df00b86e55bd92057f", "title": "Polyspecificity - An emerging trend in the development of clinical antibodies."}, {"paperId": "601a4c3a2782ade38b4dfe2789cc0755f69f2de5", "title": "Treatment persistence among bio-na\u00efve patients with Crohn\u2019s disease initiated on ustekinumab or adalimumab"}, {"paperId": "fb9aa5117f7a30c4e7f60cf7dcb25590204131ee", "title": "Real-world Comparative Effectiveness of Ustekinumab vs Anti-TNF in Crohn's Disease With Propensity Score Adjustment: Induction Phase Results From the Prospective, Observational RUN-CD Study."}, {"paperId": "7fa455610e0d67a2f8b22e01805df89bf81732a7", "title": "Improving IBD outcomes in the era of many treatment options"}, {"paperId": "c8ddd87c4e24dbdfc0e8a4ce6b547a25d5519dbb", "title": "A Practical Guide to Use of Risankizumab."}, {"paperId": "b1deddb1454ad2901cd93d805b16f37fbf5fc363", "title": "Clinical Evaluation of Risankizumab in the Treatment of Adults with Moderately to Severely Active Crohn\u2019s Disease: Patient Selection and Reported Outcomes"}, {"paperId": "06070a309e865360e118c243591d277c1fc8d28a", "title": "Is there an optimal sequence of biologic therapies for inflammatory bowel disease?"}, {"paperId": "006df2885f562e10307316401f4dab397a097cad", "title": "Systematic review with network meta\u2010analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease"}, {"paperId": "685a6443c7f9ed2df6c0e0f5c347fed1891dafbf", "title": "An update on efficacy and safety comparison of biologics in treatment of inflammatory bowel disease targeting TNF-\u03b1, interleukins, leukocyte trafficking, Janus-kinase, and sphingosine-1-phosphate receptor"}, {"paperId": "fffe928aae0f513daf2c6e238f9cfecd05805f46", "title": "Treat\u2010to\u2010target and sequencing therapies in Crohn's disease"}, {"paperId": "44c73b4bc28b603e7015310c5590d6055c650a92", "title": "Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies"}, {"paperId": "f3ab394f4fec2d0b5dacbc4ae032a07dde6d96f8", "title": "A method for identifying causal effects from heterogeneous clinical trials in the absence of a common control group: an individual participant data meta-analysis and validation study"}, {"paperId": "6bc9435720c5986096779723fd6c2f358edb7e1e", "title": "Emerging drugs for the treatment of inflammatory bowel disease"}, {"paperId": "36cc799cc33f8751c12aec3f5abe7223dddb35aa", "title": "Expression and function of \u03b14\u03b27 integrin predict the success of vedolizumab treatment in inflammatory bowel disease."}, {"paperId": "997237418ea2912586e319a551b5552a96a0ce2e", "title": "Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohn's disease."}, {"paperId": "ab17d6fbdfb76f3763b33814fb431389c876caaa", "title": "Biologics: how far can they go in Crohn\u2019s disease?"}, {"paperId": "7f31d690d12fe42b59d69fdb4c1aed1b63490bbe", "title": "Long\u2010term effectiveness of ustekinumab comparable to antitumor necrosis factor agents in patients with Crohn's disease"}, {"paperId": "46046dd3e2734ec4d6fc643779db6bccbe635fa9", "title": "Validating the Simplified Endoscopic Mucosal Assessment for Crohn\u2019s Disease: A Novel Method for Assessing Disease Activity"}, {"paperId": "686eac18ebde63218138dfe9c3358fed8562c886", "title": "Adalimumab versus ustekinumab as first-line biological in moderate-to-severe Crohn\u2019s disease: real-life cohort from a tertiary referral center"}, {"paperId": "29430de33833b87a035314ca9e42b6916ecf7522", "title": "Tackling Inflammatory Bowel Diseases: Targeting Proinflammatory Cytokines and Lymphocyte Homing"}, {"paperId": "2bcd9009734cf01a102bab21aefe4a70a3437541", "title": "The Influence of Interpersonal Trust on Rural Residents' Willingness to Participate in Mutual Aid for the Aged: An Empirical Analysis Based on the Survey Data of Hubei and Henan Provinces"}, {"paperId": "0033f20cc897df7348cccda4b2df6d212fc2afa2", "title": "Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn\u2019s disease: systematic review and network meta-analysis"}, {"paperId": "a2abdb61a6bc8a6d6819cbdbb09a117cc294646d", "title": "Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis"}, {"paperId": "c57753d6d7f4161d72e3947db0298a874af0626a", "title": "Increasing children's global access to COVID-19 vaccines"}, {"paperId": "d4a9fb997e0b28f0abd060b1d56b0fa739bcfb8a", "title": "Head-to-head biologic therapy in Crohn's disease"}, {"paperId": "fb2fce8ac5ed78f247dedfacb7c68e2ea6fec9e6", "title": "IBD: essential links of pathogenesis and drugs for intervention"}, {"paperId": "d472637b3b7e6011ac66ae25e35db0d54847f654", "title": "World Journal of Gastrointestinal Surgery"}]}
